Territorial Availability: Available through Bertin Technologies only in France
- Synonyms
- 3-carboxy-1-(methyl-d3)-pyridinium, monochloride
- Correlated keywords
- 1190984-72-5 6138-41-6 deuterated deuterium GCMS LCMS Lotus vitamin B3 PRDM-16 PGC1? UCP-1 3T3L1 interleukin IL6 TNF? IL1? IL18 PPAR nonalcoholic
- Product Overview:
Trigonelline-d3 is intended for use as an internal standard for the quantification of trigonelline (Item No. 11904) by GC- or LC-MS. Trigonelline is an alkaloid that has been found in L. japonicus and an active metabolite of niacin that has diverse biological activities.{66006,66009,66007,66008} It increases levels of the brown fat marker proteins PRDM16, PGC-1?, and UCP1 in 3T3-L1 adipocytes when used at a concentration of 75 µM.{66006} Trigonelline inhibits degranulation of, and decreases the production of IL-6 and TNF-? in, activated primary mouse bone marrow mast cells (BMMCs).{66009} In vivo, trigonelline (200 mg/kg) reduces serum IgE levels, pulmonary immune cell infiltration, and mucus secretion in a mouse model of ovalbumin-induced allergic asthma. It reduces serum levels of IL-1?, IL-6, IL-18, and malondialdehyde (MDA) and renal cell apoptosis, as well as increases protein levels of peroxisome proliferator-activated receptor ? (PPAR?) in a rat model of high-fat diet- and streptozotocin-induced type 2 diabetic nephropathy when administered at a dose of 40 mg/kg.{66007} Trigonelline (50 mg/kg) reduces hepatic de novo lipogenesis, induces hepatic autophagy, and prevents weight gain, insulin resistance, and hepatic steatosis in a mouse model of high-cholesterol and high-fat diet-induced non-alcoholic fatty liver disease (NAFLD).{66008}
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.